An open label trial of anakinra to prevent respiratory failure in COVID-19
…, IP Trontzas, K Syrigos, L Chatzis, S Chatzis… - Elife, 2021 - elifesciences.org
Background: It was studied if early suPAR-guided anakinra treatment can prevent severe
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …
[PDF][PDF] Sjögren's syndrome: one year in review 2022
V Manfrè, LG Chatzis, G Cafaro, S Fonzetti… - Clin Exp …, 2022 - clinexprheumatol.org
Primary Sjögren’s syndrome (pSS) is a complex disabling systemic autoimmune disorder.
The hallmark of pSS is the T-cell-mediated hyperactivation of B-cells, evolving from …
The hallmark of pSS is the T-cell-mediated hyperactivation of B-cells, evolving from …
[HTML][HTML] Primary Sjögren's syndrome of early and late onset: distinct clinical phenotypes and lymphoma development
…, OD Argyropoulou, VC Pezoulas, L Chatzis… - Frontiers in …, 2020 - frontiersin.org
Objectives To study the clinical, serological and histologic features of primary Sjögren’s
syndrome (pSS) patients with early (young ≤35 years) or late (old ≥65 years) onset and to …
syndrome (pSS) patients with early (young ≤35 years) or late (old ≥65 years) onset and to …
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and …
…, AV Goules, K Bitzogli, II Cinoku, LG Chatzis… - Journal of …, 2021 - Elsevier
Objectives To investigate humoral responses and safety of mRNA SARS-CoV-2 vaccines in
systemic autoimmune and autoinflammatory rheumatic disease (SAARD) patients subjected …
systemic autoimmune and autoinflammatory rheumatic disease (SAARD) patients subjected …
Clinical picture, outcome and predictive factors of lymphoma in primary Sjögren's syndrome: results from a harmonized dataset (1981–2021)
Objectives Primary Sjögren’s Syndrome (pSS) carries the highest risk for non-Hodgkin's
lymphoma (NHL) development among systemic autoimmune diseases. However, the paucity of …
lymphoma (NHL) development among systemic autoimmune diseases. However, the paucity of …
A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score
L Chatzis, AV Goules, V Pezoulas, C Baldini… - Journal of …, 2021 - Elsevier
The aim of this study is to explore the role of labial minor salivary gland (LMSG) focus score (FS)
in stratifying Sjögren's Syndrome (SS) patients, lymphoma development prediction and …
in stratifying Sjögren's Syndrome (SS) patients, lymphoma development prediction and …
[HTML][HTML] Sjögren's syndrome: the clinical spectrum of male patients
L Chatzis, VC Pezoulas, F Ferro, S Gandolfo… - Journal of clinical …, 2020 - mdpi.com
Background: To compare the clinical, serological and histologic features between male and
female patients with Sjögren’s syndrome (SS) and explore the potential effect of gender on …
female patients with Sjögren’s syndrome (SS) and explore the potential effect of gender on …
Predicting lymphoma in Sjögren's syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording
Objective Parotid swelling (PSW) is a major predictor of non-Hodgkin’s lymphoma (NHL) in
primary SS (pSS). However, since detailed information on the time of onset and duration of …
primary SS (pSS). However, since detailed information on the time of onset and duration of …
[PDF][PDF] One year in review 2021: Sjögren's syndrome
Sjögren’s syndrome (SS) is a multifactorial systemic autoimmune disease of unknown
aetiology characterised by a wide spectrum of different clinical manifestations and scattered …
aetiology characterised by a wide spectrum of different clinical manifestations and scattered …
[PDF][PDF] Sjögren's syndrome: one year in review 2023
S Longhino, LG Chatzis, R Dal Pozzolo… - Clin Exp …, 2023 - clinexprheumatol.org
Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disorder characterised by the
T-cell-mediated hyperactivation of B-cells and cytokine production. The condition may evolve …
T-cell-mediated hyperactivation of B-cells and cytokine production. The condition may evolve …